DOXORUBICINA SERVYCAL 10 mg

Doxorubicina Servycal 50 mg

Doxorubicina hydrochloride 10mg and 50 mg

Lyophilized for injection

Sale under filed prescription

Manufactured in Argentina

QUALI-QUANTITATIVE COMPOSITION:

DOXORUBICINA SERVYCAL 10 mg.:

Each vial contains:

Doxorubicin hydrochloride 10 mg.

Lactose monohydrate 30 mg.

Mannitol 20 mg

DOXORUBICINA SERVYCAL 50 mg.:

Each vial contains:

Doxorubicin hydrochloride 50 mg.

Lactose monohydrate 150 mg

Mannitol 100 mg

THERAPEUTIC ACTION:

Antineoplastic

INDICATION:

successful results were achieved in tha application of DOXORUBICIN to produce a regression in disseminated neoplastic diseases such as lymphoblastic leukemia, acute myeloblastic leukemia, Tumor Wilms, neuroblastoma, soft tissue sarcoma and osteosarcoma, breast carcinoma, ovarian carcinoma, transitional bladder carcinoma, thyroid glannd carcinoma, gastric carcinoma, "Hodgkin's disease", malignant lymphoma and lung cancer, particularly the small cell variety.

PRESENTATION:

DOXORUBICINA SERVYCAL lyophilized 10 mg and 50 mg x 1 vial.

Store between 15° and 30°C protected from light